Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Crooks

Showing results (301-310 of 319) with videos related to

Pageof 32
Sort By:
Cancer Research|September 23, 2003
NADPH oxidase activity is essential for Keap1/Nrf2-mediated induction of GCLC in response to 2-indol-3-yl-methylenequinuclidin-3-olsKonjeti R Sekhar, Peter A Crooks, Vijayakumar N Sonar, et al.
Cancer Research|May 16, 2013
KEAP1 is a redox sensitive target that arbitrates the opposing radiosensitive effects of parthenolide in normal and cancer cellsYong Xu, Fang Fang, Sumitra Miriyala, et al.
Cancer Research|November 20, 2013
The NADH oxidase ENOX1, a critical mediator of endothelial cell radiosensitization, is crucial for vascular developmentAmudhan Venkateswaran, Konjeti R Sekhar, Daniel S Levic, et al.
Pharmacological Research|August 26, 2017
Characterization of structurally novel G protein biased CB<sub>1</sub> agonists: Implications for drug developmentBenjamin M Ford, Lirit N Franks, Sherrica Tai, et al.
Frontiers in Molecular Neuroscience|January 11, 2020
A Novel Microtubule-Binding Drug Attenuates and Reverses Protein Aggregation in Animal Models of Alzheimer's DiseaseSamuel Kakraba, Srinivas Ayyadevara, Narsimha Reddy Penthala, et al.
Blood|January 30, 2008
The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic targetSaman Hewamana, Suhair Alghazal, Thet Thet Lin, et al.
Molecular Cancer Therapeutics|October 6, 2017
Pharmacological Dual Inhibition of Tumor and Tumor-Induced Functional Limitations in a Transgenic Model of Breast CancerRuizhong Wang, Poornima Bhat-Nakshatri, Maria B Padua, et al.
Cancer Research|January 20, 2007
Novel chemical enhancers of heat shock increase thermal radiosensitization through a mitotic catastrophe pathwayKonjeti R Sekhar, Vijayakumar N Sonar, Venkatraj Muthusamy, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 8, 2008
N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivityLinda P Dwoskin, Thomas E Wooters, Sangeetha P Sumithran, et al.
Free Radical Biology & Medicine|August 8, 2017
DMAPT inhibits NF-κB activity and increases sensitivity of prostate cancer cells to X-rays in vitro and in tumor xenografts in vivoMarc S Mendonca, William T Turchan, Melanie E Alpuche, et al.
Pageof 32

Showing results (301-310 of 319) with videos related to

Sort By:
Pageof 32
Cancer Research|September 23, 2003
NADPH oxidase activity is essential for Keap1/Nrf2-mediated induction of GCLC in response to 2-indol-3-yl-methylenequinuclidin-3-olsKonjeti R Sekhar, Peter A Crooks, Vijayakumar N Sonar, et al.
Cancer Research|May 16, 2013
KEAP1 is a redox sensitive target that arbitrates the opposing radiosensitive effects of parthenolide in normal and cancer cellsYong Xu, Fang Fang, Sumitra Miriyala, et al.
Cancer Research|November 20, 2013
The NADH oxidase ENOX1, a critical mediator of endothelial cell radiosensitization, is crucial for vascular developmentAmudhan Venkateswaran, Konjeti R Sekhar, Daniel S Levic, et al.
Pharmacological Research|August 26, 2017
Characterization of structurally novel G protein biased CB<sub>1</sub> agonists: Implications for drug developmentBenjamin M Ford, Lirit N Franks, Sherrica Tai, et al.
Frontiers in Molecular Neuroscience|January 11, 2020
A Novel Microtubule-Binding Drug Attenuates and Reverses Protein Aggregation in Animal Models of Alzheimer's DiseaseSamuel Kakraba, Srinivas Ayyadevara, Narsimha Reddy Penthala, et al.
Blood|January 30, 2008
The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic targetSaman Hewamana, Suhair Alghazal, Thet Thet Lin, et al.
Molecular Cancer Therapeutics|October 6, 2017
Pharmacological Dual Inhibition of Tumor and Tumor-Induced Functional Limitations in a Transgenic Model of Breast CancerRuizhong Wang, Poornima Bhat-Nakshatri, Maria B Padua, et al.
Cancer Research|January 20, 2007
Novel chemical enhancers of heat shock increase thermal radiosensitization through a mitotic catastrophe pathwayKonjeti R Sekhar, Vijayakumar N Sonar, Venkatraj Muthusamy, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 8, 2008
N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivityLinda P Dwoskin, Thomas E Wooters, Sangeetha P Sumithran, et al.
Free Radical Biology & Medicine|August 8, 2017
DMAPT inhibits NF-κB activity and increases sensitivity of prostate cancer cells to X-rays in vitro and in tumor xenografts in vivoMarc S Mendonca, William T Turchan, Melanie E Alpuche, et al.
Pageof 32